Alternatives to VigorMeds

Async-first compounded GLP-1 with a rarity for this list — free health coaching — at a flat one-price-all-doses rate. Fast and friendly up front; the strict, non-refundable fine print is the trade-off.

Semaglutide is $199 a month as either the weekly injection or a daily pill, tirzepatide is $299 bundled with B12 and glycine, and the number does not move as your dose goes up — which is the whole point if you are budgeting a year ahead rather than a month. Every plan includes a smart scale that separates fat from muscle. Two things to read before you spend the twenty minutes: no price appears anywhere on the public site until the quiz has your height, weight and date of birth, and the money-back banner on the homepage is not the guarantee written into the contract.

The complete ladder is on the page before any intake, which almost nothing else here does: semaglutide $199 a month, $549 for three months, $999 for six, $1,788 for twelve; tirzepatide $299, $797, $1,494, $2,748. Read the long tiers correctly — each is a single upfront charge rather than a smaller monthly bill, so the advertised $149 means paying a full year before the first box ships. Disclosure is above average where it counts. Andrew Meds LLC is named with a Houston address, and the practice that writes the prescription is named separately as Dr Tel X in Kennewick, Washington. Coverage is all fifty states and DC, enumerated rather than claimed, and there is an oral tirzepatide alongside the injections. The gaps: the compounding pharmacy is never named, no time to first dose is published, and a period you have partly used is not refunded.

A science-forward compounded shop with a broad peptide catalog and flat dosing — $170/mo semaglutide, $210/mo tirzepatide ongoing — but the homepage 'as low as' price is a promotional rate, and the compounding pharmacy isn't named.

A genuinely transparent tiered-pricing shop — as low as $149/mo semaglutide or $199/mo tirzepatide on the annual plan — with press mentions and bilingual support, though the oral tablet's own pricing wasn't fully itemized.

The homepage and the pricing page tell different stories, and the pricing page is the kinder one. Every figure on the homepage carries the words "with annual prepay" — semaglutide starting at $169 a month, tirzepatide at $214 — which reads as though a year up front is the only way in. Open the full pricing table and each program has four tiers, the first labeled "Monthly · No commitment": semaglutide is $199 a month with nothing prepaid, tirzepatide $249. The prepay tiers are real savings rather than a gate — $2,028 buys a year of semaglutide at an effective $169. Everything is inside the figure: clinician evaluation, prescription, medication and shipping, with no separate consult fee. Nothing is charged unless a clinician prescribes; the card is authorized at intake as a hold, and if you are not prescribed you pay nothing. Review is typically within five hours and shipping three to five days. Coverage is 48 states plus DC, with Alaska and Mississippi named as the exclusions.

The best-documented supply chain on this board — seven pharmacies with addresses and phone numbers — attached to a shop that will not show you a single price until you have started a medical intake.

There is no way to price Believe without applying to it. Its three GLP-1 treatment pages were read end to end and carry no dollar figure at all; the only number on the homepage is a badge promising nothing is charged if you are not approved. Behind the eligibility gate the menu is four plans, each flat at every dose: semaglutide $149 a month against a struck-through $249, tirzepatide $229 against $299 and marked most chosen, a microdose at $199, and a daily oral at $229. Those are competitive figures with two complications. The microdose costs $50 a month more than standard semaglutide, the reverse of what a lower dose implies. And two of the four plans never name a molecule, so you would be choosing between products without being told which drug is in them. It claims fifty-state care without listing states, names no pharmacy, and publishes no time to first dose.

The pelvic-floor brand that a lot of women already own a set of Kegel weights from, now selling compounded semaglutide at $299 a month and tirzepatide at $399, injection or oral at the same price either way. Billing is a genuine calendar month, which is rarer here than it sounds, and prepaying drops the rate to $183 a month on a year of semaglutide. Two things the landing page will not tell you. It advertises treatment 'as low as $169/MONTH' and that figure is not reachable anywhere in the catalog — the cheapest actual monthly rate is $299. And it carries an FDA warning letter from September 2025 about this drug line specifically, which it does not mention anywhere on its own site.